Topiramate Patent Expiration
Topiramate is Used for preventing migraines in patients 12 years and older. It was first introduced by Janssen Pharmaceuticals Inc
Topiramate Patents
Given below is the list of patents protecting Topiramate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Eprontia | US11433046 | Compositions and methods for treating epilepsy, seizures and other conditions | Aug 21, 2040 | Azurity |
| Eprontia | US11633374 | Compositions and methods for treating epilepsy, seizures and other conditions | Aug 21, 2040 | Azurity |
| Eprontia | US11826343 | Compositions and methods for treating epilepsy, seizures and other conditions | Aug 21, 2040 | Azurity |
| Eprontia | US11911362 | Compositions and methods for treating epilepsy, seizures and other conditions | Aug 21, 2040 | Azurity |
| Qudexy Xr | US10363224 | Extended-release topiramate capsules | Mar 19, 2033 | Upsher Smith Labs |
| Qudexy Xr | US8652527 | Extended-release topiramate capsules | Mar 19, 2033 | Upsher Smith Labs |
| Qudexy Xr | US8889190 | Extended-release topiramate capsules | Mar 19, 2033 | Upsher Smith Labs |
| Qudexy Xr | US9101545 | Extended-release topiramate capsules | Mar 19, 2033 | Upsher Smith Labs |
| Qudexy Xr | US9555005 | Extended-release topiramate capsules | Mar 19, 2033 | Upsher Smith Labs |
| Trokendi Xr | US8298576 | Sustained-release formulations of topiramate | Apr 04, 2028 | Supernus Pharms |
| Trokendi Xr | US10314790 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Trokendi Xr | US8298580 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Trokendi Xr | US8663683 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Trokendi Xr | US8877248 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Trokendi Xr | US8889191 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Trokendi Xr | US8992989 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Trokendi Xr | US9549940 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Trokendi Xr | US9555004 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Trokendi Xr | US9622983 | Sustained-release formulations of topiramate | Nov 16, 2027 | Supernus Pharms |
| Topamax |
US7125560 (Pediatric) | Pharmaceutical composition of topiramate |
Sep 01, 2019
(Expired) | Janssen Pharms |
| Topamax Sprinkle |
US7125560 (Pediatric) | Pharmaceutical composition of topiramate |
Sep 01, 2019
(Expired) | Janssen Pharms |
| Topamax | US7125560 | Pharmaceutical composition of topiramate |
Mar 01, 2019
(Expired) | Janssen Pharms |
| Topamax Sprinkle | US7125560 | Pharmaceutical composition of topiramate |
Mar 01, 2019
(Expired) | Janssen Pharms |
| Topamax |
US5998380 (Pediatric) | Treatment of migraine |
Apr 13, 2016
(Expired) | Janssen Pharms |
| Topamax |
US6503884 (Pediatric) | Migraine treatment method using topiramate and related compounds |
Apr 13, 2016
(Expired) | Janssen Pharms |
| Topamax |
US7018983 (Pediatric) | Treatment of migraine |
Apr 13, 2016
(Expired) | Janssen Pharms |
| Topamax |
US7498311 (Pediatric) | Treatment of migraine |
Apr 13, 2016
(Expired) | Janssen Pharms |
| Topamax Sprinkle |
US5998380 (Pediatric) | Treatment of migraine |
Apr 13, 2016
(Expired) | Janssen Pharms |
| Topamax Sprinkle |
US6503884 (Pediatric) | Migraine treatment method using topiramate and related compounds |
Apr 13, 2016
(Expired) | Janssen Pharms |
| Topamax Sprinkle |
US7018983 (Pediatric) | Treatment of migraine |
Apr 13, 2016
(Expired) | Janssen Pharms |
| Topamax Sprinkle |
US7498311 (Pediatric) | Treatment of migraine |
Apr 13, 2016
(Expired) | Janssen Pharms |
| Topamax | US5998380 | Treatment of migraine |
Oct 13, 2015
(Expired) | Janssen Pharms |
| Topamax | US6503884 | Migraine treatment method using topiramate and related compounds |
Oct 13, 2015
(Expired) | Janssen Pharms |
| Topamax | US7018983 | Treatment of migraine |
Oct 13, 2015
(Expired) | Janssen Pharms |
| Topamax | US7498311 | Treatment of migraine |
Oct 13, 2015
(Expired) | Janssen Pharms |
| Topamax Sprinkle | US5998380 | Treatment of migraine |
Oct 13, 2015
(Expired) | Janssen Pharms |
| Topamax Sprinkle | US6503884 | Migraine treatment method using topiramate and related compounds |
Oct 13, 2015
(Expired) | Janssen Pharms |
| Topamax Sprinkle | US7018983 | Treatment of migraine |
Oct 13, 2015
(Expired) | Janssen Pharms |
| Topamax Sprinkle | US7498311 | Treatment of migraine |
Oct 13, 2015
(Expired) | Janssen Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Topiramate's patents.
Latest Legal Activities on Topiramate's Patents
Given below is the list recent legal activities going on the following patents of Topiramate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 30 Apr, 2024 | US8298580(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Feb, 2023 | US9101545 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 Jan, 2023 | US10363224 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 12 Dec, 2022 | US10314790(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 May, 2022 | US8889191(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 May, 2022 | US8889190 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 04 May, 2022 | US8877248 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Aug, 2021 | US8652527(Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 19 Oct, 2020 | US9622983(Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 31 Jul, 2020 | US9555004(Litigated) |
Topiramate's Family Patents
Explore Our Curated Drug Screens
Topiramate Generic API Manufacturers
Several generic applications have been filed for Topiramate. The first generic version for Topiramate was by Accord Healthcare Inc and was approved on Mar 27, 2009. And the latest generic version is by Amta Labs Ltd and was approved on Dec 3, 2024.
Given below is the list of companies who have filed for Topiramate generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 50MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
2. ACTAVIS LABS FL
Actavis Laboratories Fl Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 10, 2023 |
| 25MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 10, 2023 |
| 100MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 10, 2023 |
| 200MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 10, 2023 |
3. ACTAVIS TOTOWA
Actavis Totowa Llc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Actavis Totowa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
| 100MG | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
| 25MG | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
| 50MG | tablet | Discontinued | ORAL | N/A | Feb 27, 2013 |
Manufacturing Plant Locations New
Actavis Totowa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Totowa as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
4. AIPING PHARM INC
Aiping Pharmaceutical Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2010 |
| 200MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2010 |
| 100MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2010 |
| 50MG | tablet | Discontinued | ORAL | N/A | Jan 7, 2010 |
5. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 15, 2023 |
| 100MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 15, 2023 |
| 25MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 15, 2023 |
| 200MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 15, 2023 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 6 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule, extended release | Prescription | ORAL | AB1 | Jun 20, 2023 |
| 25MG | capsule | Prescription | ORAL | AB | Jun 13, 2024 |
| 50MG | capsule, extended release | Prescription | ORAL | AB1 | Jun 20, 2023 |
| 200MG | capsule, extended release | Prescription | ORAL | AB1 | Jun 20, 2023 |
| 15MG | capsule | Prescription | ORAL | AB | Jun 13, 2024 |
| 25MG/ML | solution | Prescription | ORAL | AB | Oct 31, 2024 |
7. AMTA
Amta Labs Ltd has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Amta.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule, extended release | Prescription | ORAL | AB2 | Dec 3, 2024 |
| 50MG | capsule, extended release | Prescription | ORAL | AB2 | Dec 3, 2024 |
| 100MG | capsule, extended release | Prescription | ORAL | AB2 | Dec 3, 2024 |
| 150MG | capsule, extended release | Prescription | ORAL | AB2 | Dec 3, 2024 |
| 200MG | capsule, extended release | Prescription | ORAL | AB2 | Dec 3, 2024 |
Manufacturing Plant Locations New
Amta's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Amta as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
8. ASCENT PHARMS INC
Ascent Pharmaceuticals Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Prescription | ORAL | AB | Aug 26, 2021 |
| 200MG | tablet | Prescription | ORAL | AB | Aug 26, 2021 |
| 50MG | tablet | Prescription | ORAL | AB | Aug 26, 2021 |
| 25MG | tablet | Prescription | ORAL | AB | Aug 26, 2021 |
9. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 25MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 50MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
10. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Prescription | ORAL | AB | Sep 27, 2023 |
| 15MG | capsule | Prescription | ORAL | AB | Sep 27, 2023 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
11. BARR
Barr Laboratories Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Barr.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Discontinued | ORAL | N/A | Apr 15, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 15MG | capsule | Discontinued | ORAL | N/A | Apr 15, 2009 |
Manufacturing Plant Locations New
Barr's manufacturing plants are situated in 4 countries - Mexico, Singapore, United States, Philippines. Given below are the details of these plant locations as well as the firm names of Barr as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mexico |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Singapore |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Philippines |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12. CHARTWELL
Chartwell Life Molecules Llc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Chartwell.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | tablet | Discontinued | ORAL | N/A | Sep 11, 2013 |
| 200MG | tablet | Discontinued | ORAL | N/A | Sep 11, 2013 |
| 100MG | tablet | Discontinued | ORAL | N/A | Sep 11, 2013 |
| 25MG | tablet | Discontinued | ORAL | N/A | Sep 11, 2013 |
Manufacturing Plant Locations New
Chartwell's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Chartwell as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||
13. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Discontinued | ORAL | N/A | Oct 14, 2009 |
| 15MG | capsule | Discontinued | ORAL | N/A | Oct 14, 2009 |
14. CIPLA LTD
Cipla Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Cipla Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 50MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
Manufacturing Plant Locations New
Cipla Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
15. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule, extended release | Prescription | ORAL | AB1 | Nov 17, 2023 |
| 200MG | capsule, extended release | Prescription | ORAL | AB1 | Nov 17, 2023 |
| 100MG | capsule, extended release | Prescription | ORAL | AB1 | Nov 17, 2023 |
| 50MG | capsule, extended release | Prescription | ORAL | AB1 | Nov 17, 2023 |
16. ENDO OPERATIONS
Endo Operations Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | capsule, extended release | Prescription | ORAL | AB1 | Mar 1, 2023 |
| 25MG | capsule, extended release | Prescription | ORAL | AB1 | May 4, 2023 |
| 100MG | capsule, extended release | Prescription | ORAL | AB1 | May 4, 2023 |
| 50MG | capsule, extended release | Prescription | ORAL | AB1 | May 4, 2023 |
17. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Prescription | ORAL | AB | Jul 16, 2024 |
| 50MG | capsule, extended release | Prescription | ORAL | AB2 | Feb 1, 2021 |
| 100MG | capsule, extended release | Prescription | ORAL | AB2 | Feb 1, 2021 |
| 200MG | capsule, extended release | Prescription | ORAL | AB2 | Feb 1, 2021 |
| 150MG | capsule, extended release | Prescription | ORAL | AB2 | Feb 1, 2021 |
| 15MG | capsule | Prescription | ORAL | AB | Jul 16, 2024 |
18. HIKMA PHARMS
Hikma Pharmaceuticals has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Hikma Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | tablet | Discontinued | ORAL | N/A | Nov 25, 2013 |
| 25MG | tablet | Discontinued | ORAL | N/A | Nov 25, 2013 |
| 100MG | tablet | Discontinued | ORAL | N/A | Nov 25, 2013 |
| 200MG | tablet | Discontinued | ORAL | N/A | Nov 25, 2013 |
19. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 50MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 25MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
20. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule, extended release | Prescription | ORAL | AB1 | Jul 11, 2024 |
| 200MG | capsule, extended release | Prescription | ORAL | AB1 | Jul 11, 2024 |
| 50MG | capsule, extended release | Prescription | ORAL | AB1 | Jul 11, 2024 |
| 25MG | capsule, extended release | Prescription | ORAL | AB1 | Jul 11, 2024 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
21. NATCO
Natco Pharma Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 50MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
Manufacturing Plant Locations New
Natco's manufacturing plants are situated in 2 countries - United Kingdom, India. Given below are the details of these plant locations as well as the firm names of Natco as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Kingdom |
| |||||||||||||
| India |
| |||||||||||||
22. PLIVA HRVATSKA DOO
Pliva Hrvatska Doo has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Pliva Hrvatska Doo.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Discontinued | ORAL | N/A | Mar 30, 2009 |
| 25MG | tablet | Discontinued | ORAL | N/A | Mar 30, 2009 |
| 50MG | tablet | Discontinued | ORAL | N/A | Mar 30, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 30, 2009 |
23. ROXANE
Roxane Laboratories Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Roxane.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 50MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
24. SENORES PHARMS
Senores Pharmaceuticals Inc has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Senores Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Prescription | ORAL | AB | Oct 10, 2024 |
| 15MG | capsule | Prescription | ORAL | AB | Oct 10, 2024 |
25. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | capsule | Prescription | ORAL | AB | Oct 14, 2009 |
| 25MG | capsule | Prescription | ORAL | AB | Oct 14, 2009 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
26. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 50MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 25MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
27. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
28. TEVA
Teva Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Prescription | ORAL | AB | Apr 17, 2009 |
| 50MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 15MG | capsule | Prescription | ORAL | AB | Apr 17, 2009 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| India |
| |||||||||
| Canada |
| |||||||||
| Czech Republic |
| |||||||||
| Ireland |
| |||||||||
| Israel |
| |||||||||
29. TORRENT PHARMS
Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Torrent Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 25MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 50MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
30. TWI PHARMS
Twi Pharmaceuticals Inc has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Twi Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Prescription | ORAL | AB | Dec 5, 2023 |
| 15MG | capsule | Prescription | ORAL | AB | Dec 5, 2023 |
31. UNICHEM LABS LTD
Unichem Laboratories Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Unichem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 50MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 25MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Feb 19, 2013 |
32. VIWIT PHARM
Viwit Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Viwit Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 50MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 100MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
Manufacturing Plant Locations New
Viwit Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Viwit Pharm as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
33. WATSON LABS
Watson Laboratories Inc has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Discontinued | ORAL | N/A | Apr 15, 2009 |
| 50MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 200MG | tablet | Discontinued | ORAL | N/A | Mar 27, 2009 |
| 15MG | capsule | Discontinued | ORAL | N/A | Apr 15, 2009 |
34. WOCKHARDT
Wockhardt Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Wockhardt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Discontinued | ORAL | N/A | Sep 1, 2010 |
| 25MG | tablet | Discontinued | ORAL | N/A | Sep 1, 2010 |
| 100MG | tablet | Discontinued | ORAL | N/A | Sep 1, 2010 |
| 50MG | tablet | Discontinued | ORAL | N/A | Sep 1, 2010 |
Manufacturing Plant Locations New
Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
35. XIAMEN LP PHARM CO
Xiamen Lp Pharmacuetical Co Ltd has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Xiamen Lp Pharm Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 5, 2024 |
| 50MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 5, 2024 |
| 100MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 5, 2024 |
| 150MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 5, 2024 |
| 200MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 5, 2024 |
36. ZYDUS
Zydus Worldwide Dmcc has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Zydus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 29, 2022 |
| 100MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 29, 2022 |
| 25MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 29, 2022 |
| 150MG | capsule, extended release | Prescription | ORAL | AB2 | Nov 29, 2022 |
| 200MG | capsule, extended release | Prescription | ORAL | AB1 | Oct 30, 2023 |
Manufacturing Plant Locations New
Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||
37. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Topiramate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | capsule, extended release | Discontinued | ORAL | N/A | Feb 9, 2023 |
38. ZYDUS PHARMS USA INC
Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | capsule | Prescription | ORAL | AB | Oct 14, 2009 |
| 50MG | capsule | Prescription | ORAL | N/A | Oct 23, 2024 |
| 100MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 200MG | tablet | Prescription | ORAL | AB | Mar 27, 2009 |
| 15MG | capsule | Prescription | ORAL | AB | Oct 14, 2009 |